AsthmaSYMPTOMESNCT00770250

National Survey on Asthma

An observational study of Asthma, run by AstraZeneca at 905 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Trial summary

To evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control. Read more about this study

Who is it for?: Ages 18 years and older
Conditions the study is for: Asthma
How many people: 1,704 participants
Where: 905 sitesFrance
Study dates: Sep 2008to Mar 2009
Phase: Observational
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
No healthy volunteers
Adult, Older adult

Study population: The first 2 consecutive patients seen during the GP's visit with a diagnosis of persistent asthma

Who may be able to join

A diagnosis of persistent asthma treated with an inhaled corticosteroid based maintenance treatment for more than 3 months
Given his/her consent to participate to the study and who is able to answer the questionnaire in french by him/her-self.

Who cannot join

Patient with a cardiac disease (congestive heart failure, coronary artery disease)
Patient with a respiratory disease other than asthma (COPD, sleep apnea syndrome).

Trial locations and contacts

905 sites in 1 country.

City, postcode or hospital

300 sites in 1 country

France300 sites

Research Site
Abbeville
Research Site
Ablon-sur-Seine
Research Site
Agneaux
Research Site
Agon-Coutainville
Research Site
Aignay-le-Duc
Research Site
Aigrefeuille-d'Aunis
Research Site
Aigrefeuille-sur-Maine
Research Site
Aigurande
Research Site
Airvault
Research Site
Aiserey
Research Site
Aix-en-Provence
Research Site
Ajaccio
Research Site
Alès
Research Site
Alligny-Cosne
Research Site
Allonnes
Research Site
Althen-des-Paluds
Research Site
Ambazac
Research Site
Ambès
Research Site
Amiens
Research Site
Andé
Research Site
Andrézieux-Bouthéon
Research Site
Angers
Research Site
Anglet
Research Site
Angoulême
Research Site
Antibes
Research Site
Antony
Research Site
Anzin
Research Site
Argences
Research Site
Argenteuil
Research Site
Arques-la-Bataille
Research Site
Arsac
Research Site
Arudy
Research Site
Aspiran
Research Site
Athis-Mons
Research Site
Aubenas
Research Site
Auchel
Research Site
Audierne
Research Site
Audincourt
Research Site
Aulnay-sous-Bois
Research Site
Auriol
Research Site
Autrans
Research Site
Autun
Research Site
Auvers-sur-Oise
Research Site
Auxi-le-Château
Research Site
Auxonne
Research Site
Avelin
Research Site
Avignon
Research Site
Axat
Research Site
Bâgé-le-Châtel
Research Site
Bagnères-de-Bigorre
Research Site
Bagneux
Research Site
Bagnolet
Research Site
Bagnols-sur-Cèze
Research Site
Baignes Ste Radegonde
Research Site
Baillet-en-France
Research Site
Balaruc-le-Vieux
Research Site
Ballon
Research Site
Balma
Research Site
Barentin
Research Site
Basse-Goulaine
Research Site
Bassillac
Research Site
Bayonne
Research Site
Beaulieu-sur-Dordogne
Research Site
Beaumetz-lès-Aire
Research Site
Beaumont
Research Site
Beaumont-sur-Oise
Research Site
Bellac
Research Site
Bellegarde-sur-Valserine
Research Site
Bellême
Research Site
Belleville-sur-Meuse
Research Site
Bergerac
Research Site
Bergues
Research Site
Berre-l'Étang
Research Site
Bersée
Research Site
Beuvrages
Research Site
Béziers
Research Site
Bezons
Research Site
Biganos
Research Site
Bihorel
Research Site
Billy-Montigny
Research Site
Blangy-sur-Bresle
Research Site
Blénod-lès-Pont-à-Mousson
Research Site
Blotzheim
Research Site
Boën-sur-Lignon
Research Site
Bohars
Research Site
Boos
Research Site
Bordeaux
Research Site
Bords
Research Site
Bormes-les-Mimosas
Research Site
Bort-les-Orgues
Research Site
Bouère
Research Site
Bouffémont
Research Site
Bougival
Research Site
Bourbriac
Research Site
Bourg-Achard
Research Site
Bourg-la-Reine
Research Site
Bourron-Marlotte
Research Site
Bourth
Research Site
Bousbecque
Research Site
Bouzonville
Research Site
Boynes
Research Site
Brax
Research Site
Brebières
Research Site
Brest
Research Site
Breuil-le-Sec
Research Site
Brignoud
Research Site
Broût-Vernet
Research Site
Bruay-la-Buissière
Research Site
Bucquoy
Research Site
Bulgnéville
Research Site
Bussang
Research Site
Bussy-Saint-Georges
Research Site
Calvisson
Research Site
Canet-en-Roussillon
Research Site
Cannes
Research Site
Canteleu
Research Site
Cany-Barville
Research Site
Capdenac-Gare
Research Site
Capestang
Research Site
Carbon-Blanc
Research Site
Carcassonne
Research Site
Carhaix-Plouguer
Research Site
Carresse-Cassaber
Research Site
Carvin
Research Site
Cassis
Research Site
Castelnau-Montratier
Research Site
Castres
Research Site
Caudebec-lès-Elbeuf
Research Site
Caulnes
Research Site
Caylus
Research Site
Cénac
Research Site
Cérilly
Research Site
Cernay
Research Site
Chacé
Research Site
Chalais
Research Site
Chaleins
Research Site
Chalindrey
Research Site
Chalon-sur-Saône
Research Site
Châlons-en-Champagne
Research Site
Chambly
Research Site
Champagné-les-Marais
Research Site
Champagnole
Research Site
Champeix
Research Site
Champigny-sur-Marne
Research Site
Champniers
Research Site
Chanceaux-sur-Choisille
Research Site
Chantonnay
Research Site
Chaource
Research Site
Charensat
Research Site
Charenton-le-Pont
Research Site
Charleville-Mézières
Research Site
Charroux
Research Site
Château-d'Olonne
Research Site
Château-Thierry
Research Site
Châteaubriant
Research Site
Châteaugay
Research Site
Châteauneuf-sur-Cher
Research Site
Châteauroux
Research Site
Châtenay-Malabry
Research Site
Châtenois
Research Site
Châtillon-en-Vendelais
Research Site
Châtillon-sur-Chalaronne
Research Site
Chauvigny
Research Site
Chavanges
Research Site
Chazay-d'Azergues
Research Site
Cherbourg Octeville
Research Site
Choisey
Research Site
Choisy-le-Roi
Research Site
Cholet
Research Site
Ciboure
Research Site
Cires-lès-Mello
Research Site
Civrac-de-Blaye
Research Site
Clairac
Research Site
Clamart
Research Site
Clapiers
Research Site
Clermont-Ferrand
Research Site
Clessé
Research Site
Cognac
Research Site
Colleville-Montgomery
Research Site
Colmar
Research Site
Colomars
Research Site
Colombey-les-Belles
Research Site
Colomiers
Research Site
Combs-la-Ville
Research Site
Conches-sur-Gondoire
Research Site
Condé-sur-Noireau
Research Site
Conflans Ste Honorine
Research Site
Corbeil-Essonnes
Research Site
Corné
Research Site
Corsept
Research Site
Corseul
Research Site
Coudekerque-Branche
Research Site
Courbevoie
Research Site
Courcelles-lès-Lens
Research Site
Courçon
Research Site
Cournon-d'Auvergne
Research Site
Courpière
Research Site
Coursan
Research Site
Courtry
Research Site
Couze-et-Saint-Front
Research Site
Creil
Research Site
Créteil
Research Site
Criquetot-l'Esneval
Research Site
Crolles
Research Site
Cros-de-Cagnes
Research Site
Cugnaux
Research Site
Cysoing
Research Site
Dangé-Saint-Romain
Research Site
Danjoutin
Research Site
Décines-Charpieu
Research Site
Deûlémont
Research Site
Dieuze
Research Site
Diéval
Research Site
Digne-les-Bains
Research Site
Digoin
Research Site
Dijon
Research Site
Docelles
Research Site
Dole
Research Site
Douarnenez
Research Site
Douchy-les-Mines
Research Site
Dourdan
Research Site
Drancy
Research Site
Drap
Research Site
Dun-le-Palestel
Research Site
Dunkirk
Research Site
Eaubonne
Research Site
Échirolles
Research Site
Élancourt
Research Site
Elna
Research Site
Enveig
Research Site
Épernay
Research Site
Épieds-en-Beauce
Research Site
Épinay-sur-Seine
Research Site
Équeurdreville-Hainneville
Research Site
Ermont
Research Site
Esquerdes
Research Site
Essars
Research Site
Essey-lès-Nancy
Research Site
Étain
Research Site
Étampes
Research Site
Étival-Clairefontaine
Research Site
Étupes
Research Site
Évaux-les-Bains
Research Site
Évin-Malmaison
Research Site
Évry
Research Site
Excideuil
Research Site
Exincourt
Research Site
Falaise
Research Site
Fécamp
Research Site
Feignies
Research Site
Fenain
Research Site
Fermanville
Research Site
Feurs
Research Site
Firminy
Research Site
Fitilieu
Research Site
Fleurance
Research Site
Fleury-les-Aubrais
Research Site
Fleury-sur-Andelle
Research Site
Fleury-sur-Orne
Research Site
Florac
Research Site
Folembray
Research Site
Fontaine
Research Site
Fontenay-sous-Bois
Research Site
Forges-les-Eaux
Research Site
Fos-sur-Mer
Research Site
Fougères
Research Site
Foussais-Payré
Research Site
Franconville
Research Site
Fronton
Research Site
Fumay
Research Site
Gagny
Research Site
Gaillefontaine
Research Site
Gallardon
Research Site
Gandrange
Research Site
Gap
Research Site
Gauchy
Research Site
Gelles
Research Site
Gelos
Research Site
Gennevilliers
Research Site
Gentilly
Research Site
Ger
Research Site
Gerbéviller
Research Site
Gerzat
Research Site
Gif-sur-Yvette
Research Site
Givors
Research Site
Gondrecourt-le-Château
Research Site
Gondreville
Research Site
Gorges
Research Site
Goudelin
Research Site
Grand-Couronne
Research Site
Granville
Research Site
Graulhet
Research Site
Grenade
Research Site
Grenoble
Research Site
Gréoux-les-Bains
Research Site
Grignols
Research Site
Guenrouet
Research Site
Guerlesquin
Research Site
Guichen
Research Site
Guidel

Other trials in France

About this study

Official title: A Mirror Assessment of the Words Used By Patients and Physicians to Express Asthma Symptoms, According To the Patient's Level of Asthma Control In General Medicine

To evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control.

Conditions: Asthma
Keywords: asthma symptoms, words used by patients and physicians, express asthma symptoms
Medical subject headings: Asthma

What is being measured

The primary outcome is the main question the study is designed to answer.

The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control.
Measured: Once

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

Sep 2008Mar 2009

First posted9 Oct 2008 (estimated)
Study startSep 2008
Study completionMar 2009

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for AsthmaStudies of the same condition, open and under way.
More trials run by AstraZenecaThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Observational
Observational model: Cohort
Time perspective: Cross-sectional
Enrolment: 1,704 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT00770250
Sponsor's protocol ID: NIS-RFR-DUM-2008/1
Acronym: SYMPTOMES
Status last verified: Nov 2010
First submitted: 7 Oct 2008
Last updated: 2 Dec 2010
Results posted: No
Data monitoring committee: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

RecruitingObservational study
Asthma and Primary Arterial Hypertension: an Inflammatory Link?
Asthma Bronchial
RecruitingPhase 3
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
Asthma
Enrolling by invitationObservational study
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
RecruitingPhase 2
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Asthma
Active, not recruitingPhase 1
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Asthma

All Asthma trials

Study at a glance

From the registry record, last updated by the sponsor on 2 Dec 2010. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: A Mirror Assessment of the Words Used By Patients and Physicians to Express Asthma Symptoms, According To the Patient's Level of Asthma Control In General Medicine
ClinicalTrials.gov ID: NCT00770250
Acronym / sponsor ID: SYMPTOMES / NIS-RFR-DUM-2008/1
Conditions: Asthma
Keywords: asthma symptoms, words used by patients and physicians, express asthma symptoms
Study type: Observational
Recruitment status: Completed
Enrolment: 1,704 participants (actual)
Lead sponsor: AstraZenecaIndustry (pharma, biotech, devices)
Study start: Sep 2008
Study completion: Mar 2009 (actual)
First posted: 9 Oct 2008 (estimated)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

To evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control.

Study design

Observational model: Cohort
Time perspective: Cross-sectional

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult, Older adult
Study population: The first 2 consecutive patients seen during the GP's visit with a diagnosis of persistent asthma

Key inclusion criteria (2 listed)

A diagnosis of persistent asthma treated with an inhaled corticosteroid based maintenance treatment for more than 3 months
Given his/her consent to participate to the study and who is able to answer the questionnaire in french by him/her-self.

Key exclusion criteria (2 listed)

Patient with a cardiac disease (congestive heart failure, coronary artery disease)
Patient with a respiratory disease other than asthma (COPD, sleep apnea syndrome).

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Primary outcome

The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control.
Time frame: Once

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 2 Dec 2010.

Related trials for Asthma

RecruitingObservational study
Asthma and Primary Arterial Hypertension: an Inflammatory Link?
Asthma Bronchial
RecruitingPhase 3
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
Asthma
Enrolling by invitationObservational study
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
RecruitingPhase 2
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Asthma
Active, not recruitingPhase 1
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Asthma

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Alain Castaigne study director

AstraZeneca

905 sites in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

An observational study of Asthma, run by AstraZeneca at 905 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Dec 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 905 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control. (time frame: Once). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00770250.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Dec 2010.